Area of research
Cardiology and Cardiovascular Medicine · Biomedical Engineering
Research interest
Research interests include Heart Failure Treatment and Management, Acute Myocardial Infarction Research, Mechanical Circulatory Support Devices, and Cardiac Imaging and Diagnostics.
Immune checkpoint inhibitor-associated myocarditis: a novel risk score
Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction
SGLT2 Inhibitors for the Prevention and Treatment of Heart Failure: A Scientific Statement of the HFA and the HFAI
Colchicine in acute myocardial infarction: cardiovascular events at 1-year follow up
Ventilation strategies in cardiogenic shock: insights from the FRENSHOCK observational registry
Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy
Mottling as a prognosis marker in cardiogenic shock
Beta-blocker management in patients admitted for acute heart failure and reduced ejection fraction: a review and expert consensus opinion
Impella for the Management of Ventricular Septal Defect Complicating Acute Myocardial Infarction: A European Multicenter Registry
Practical outpatient management of worsening chronic heart failure
Prevalence of psychoactive drug use in patients hospitalized for acute cardiac events: Rationale and design of the ADDICT-ICCU trial, from the Emergency and Acute Cardiovascular Care Working Group and the National College of Cardiologists in Training of the French Society of Cardiology
Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction
Fractional Flow Reserve to Guide Treatment of Patients With Multivessel Coronary Artery Disease
Baseline Characteristics, Management, and Predictors of Early Mortality in Cardiogenic Shock: Insights from the FRENSHOCK Registry
Compared Outcomes of ST-Segment–Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER-MI Trial
Colchicine for Left Ventricular Infarct Size Reduction in Acute Myocardial Infarction: A Phase II, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Protocol – The COVERT-MI Study
Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
Predictive value of early cardiac magnetic resonance imaging functional and geometric indexes for adverse left ventricular remodelling in patients with anterior ST-segment elevation myocardial infarction: A report from the CIRCUS study
Design and preliminary results of FRENSHOCK 2016: A prospective nationwide multicentre registry on cardiogenic shock
Pre-PCI angiographic TIMI flow in the culprit coronary artery influences infarct size and microvascular obstruction in STEMI patients
The RIPOST-MI study, assessing remote ischemic perconditioning alone or in combination with local ischemic postconditioning in ST-segment elevation myocardial infarction
Systems Medicine Approaches for the Definition of Complex Phenotypes in Chronic Diseases and Ageing. From Concept to Implementation and Policies
No post-conditioning in the human heart with thrombolysis in myocardial infarction flow 2-3 on admission
Postconditioning attenuates no-reflow in STEMI patients
Post-Conditioning Reduces Infarct Size and Edema in Patients With ST-Segment Elevation Myocardial Infarction
Cardioprotection by clopidogrel in acute ST-elevated myocardial infarction patients: a retrospective analysis